Top Buy
| Wertpapier ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals | 27 | 1 | 4 | 0 | 23,57 € | 27,38 € | 16,16 % |
| Agios Pharmaceuticals Inc. | 11 | 1 | 6 | 0 | 24,00 € | 43,63 € | 81,77 % |
| Alkermes plc | 17 | 0 | 4 | 0 | 25,00 € | 38,70 € | 54,81 % |
| Alnylam Pharmace. | 51 | 0 | 0 | 0 | 393,40 € | 456,30 € | 15,99 % |
| Amedisys Inc. | 1 | 0 | 0 | 0 | 84,50 € | 88,29 € | 4,49 % |
| Amicus Therapeutics Inc. | 5 | 0 | 1 | 0 | 8,30 € | 16,39 € | 97,45 % |
| Arrowhead Pharmaceuticals Inc. | 19 | 0 | 6 | 0 | 52,76 € | 64,41 € | 22,09 % |
| BB Biotech AG | 1 | 0 | 0 | 0 | 49,60 € | - | - |
| Bio-Rad Labs Inc. A | 7 | 0 | 0 | 0 | 274,70 € | 352,72 € | 28,40 % |
| Bio-Techne Corp. | 17 | 0 | 3 | 0 | 53,00 € | 60,82 € | 14,76 % |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | 111,15 € | - | - |
| Bruker Corp. | 15 | 0 | 1 | 0 | 41,24 € | 45,57 € | 10,49 % |
| Charles River Labs Intl | 19 | 0 | 4 | 0 | 158,25 € | 165,88 € | 4,82 % |
| Chemed Corp. | 9 | 0 | 1 | 0 | 360,00 € | 515,26 € | 43,13 % |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | 97,50 € | - | - |
| Emergent Biosolutions Inc. | 9 | 0 | 2 | 0 | 10,24 € | 14,23 € | 39,02 % |
| Ensign Group Inc. | 9 | 0 | 1 | 0 | 153,00 € | 159,91 € | 4,51 % |
| Exelixis Inc. | 40 | 0 | 0 | 0 | 38,09 € | 40,48 € | 6,27 % |
| Genus plc | 1 | 0 | 1 | 0 | 29,20 € | - | - |
| Glaukos Corp | 1 | 0 | 0 | 0 | 91,50 € | - | - |
| Globus Medical A | 1 | 0 | 0 | 0 | 75,50 € | 76,00 € | 0,66 % |
| GN Store Nord A/S | 1 | 0 | 0 | 0 | 13,96 € | - | - |
| Haemonetics Corp. | 17 | 1 | 3 | 0 | 72,00 € | 76,78 € | 6,64 % |
| Halozyme Therapeutics Inc. | 21 | 2 | 3 | 1 | 54,40 € | 67,75 € | 24,54 % |
| Icon plc | 21 | 0 | 0 | 0 | 159,60 € | 203,65 € | 27,60 % |